Jotbody makes Forbes Asia’s 100 companies to watch in 2023
We have some exciting news to share with our Jotbody community! We are thrilled to announce that Jotbody has been selected as one of Forbes Asia’s “100 Companies to Watch in 2023.” This prestigious recognition highlights our commitment to excellence and innovation in the Biotechnology and Healthcare sector.
Forbes Asia’s annual list showcases small companies and startups that are making waves in Asia by targeting underserved markets or leveraging cutting-edge technologies. Being included among these trailblazing companies is a testament to Jotbody’s potential for success and growth in the coming year.
The selection process was rigorous, with over 550 submissions evaluated. The final 100 companies were chosen based on their positive impact on the region or industry, revenue growth, funding attraction, promising business models or markets, and compelling stories.
We extend our heartfelt gratitude to our dedicated team, loyal customers, and valued partners for their unwavering support on our journey. This recognition would not have been possible without your trust and collaboration.
Being named one of Forbes Asia’s 100 Companies to Watch in 2023 motivates us to continue delivering cutting-edge solutions, fostering innovation, and making a positive impact in this sector. We are excited about the future and the opportunities that lie ahead.
We invite you to explore the complete list of Forbes Asia’s 100 Companies to Watch in 2023 on their website (https://www.forbes.com/sites/forbesasiateam/2023/08/28/forbes-asia-100-to-watch-2023/?sh=14d0068c75a1). It’s an excellent opportunity to discover other remarkable companies and gain insights into the latest trends and innovations shaping the Asian business landscape.
As we celebrate this achievement, we remain committed to our mission of providing the best nanobody services. Stay tuned for more exciting updates and developments from Jotbody as we continue to strive for excellence!